Skip to main content

SEI INVESTMENTS CO

Position in NBIX — Neurocrine Biosciences Inc

CIK 350894 OAKS, PA

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$30,991,966
+$5,548,091 QoQ
Shares Held
235,251
+31.1% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SEI INVESTMENTS CO holds $466,534,849 across 39 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
235,251 $30,991,966

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,991,966 235,251
2025-12-31 $25,443,875 179,397
2025-09-30 $42,141,373 300,195
2025-06-30 $27,747,198 220,759
2025-03-31 $15,641,604 141,425
2024-12-31 $20,532,876 150,424
2024-09-30 $17,872,810 155,119
2024-06-30 $17,623,962 128,016
2024-03-31 $11,953,388 86,669
2023-12-31 $15,278,626 115,958
2023-09-30 $10,185,975 90,542
2023-06-30 $8,542,542 90,589
2023-03-31 $8,519,889 84,172
2022-12-31 $13,434,968 112,483
2022-09-30 $11,705,721 110,213
2022-06-30 $5,722,172 58,701
2022-03-31 $5,327,062 56,822
2021-12-31 $5,150,144 60,469
2021-09-30 $5,541,104 57,774
2021-06-30 $5,614,001 57,686
2021-03-31 $5,859,798 60,255
2020-12-31 $8,247,220 86,043
2020-09-30 $6,463,586 67,217
2020-06-30 $8,914,906 73,073
2020-03-31 $6,055,816 69,969